Paul D Rubin
Chief Medical Officer at BioAge Labs, Inc. (BIOA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 3SEC | BIOABioAge Labs, Inc. | Sell Plan | 8,820 | $17.81 | $157K | -64.4% |
| Mar 3SEC | BIOABioAge Labs, Inc. | Sell Plan | 7,433 | $20.30 | $151K | -68.8% |
| Feb 3SEC | BIOABioAge Labs, Inc. | Sell Plan | 7,433 | $18.75 | $139K | -66.2% |
| Jan 6SEC | BIOABioAge Labs, Inc. | Sell Plan | 7,433 | $12.85 | $96K | -50.7% |
| Dec 11SEC | BIOABioAge Labs, Inc. | Sell Plan | 18,000 | $12.00 | $216K | -47.2% |
| Dec 5SEC | BIOABioAge Labs, Inc. | Sell Plan | 68,897 | $10.19 | $702K | -37.8% |
- Sell
Chief Medical Officer Paul D Rubin sold $157K of BIOA at $17.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Paul D Rubin sold $151K of BIOA at $20.30 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Paul D Rubin sold $139K of BIOA at $18.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Paul D Rubin sold $96K of BIOA at $12.85 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Paul D Rubin sold $216K of BIOA at $12.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Paul D Rubin sold $702K of BIOA at $10.19 — pre-scheduled 10b5-1 plan sale.